Pack Size/Qty | Price | Unit Price | |
9 Inhaler/s | $285.00 | $31.70 | |
6 Inhaler/s | $244.00 | $40.80 | |
3 Inhaler/s | $138.00 | $46.00 |
Generic Name : Formoterol Fumarate And Fluticasone Propionate
Brand Name : Foradil Aerolizer + Flovent
Manufacturer Name : Cipla Ltd - Pharmaceutical Company
Product Code : CRX 163
Delivery Days : 10 to 15 working days
Strength : 250/6 MCG
Packaging : Inhaler
The Maxiflo Inhaler 250/6mcg is a pharmaceutical product designed to provide relief and treatment for individuals suffering from various respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD). This inhaler is a combination of two active ingredients: fluticasone propionate and salmeterol xinafoate. In this comprehensive description, we will delve into the key aspects of Maxiflo Inhaler 250/6mcg, including its composition, mechanism of action, indications, usage, potential side effects, precautions, and more.
Maxiflo Inhaler 250/6mcg is a combination inhaler, which means it contains two active ingredients that work in synergy to address the symptoms and underlying causes of respiratory conditions.
Fluticasone Propionate (250mcg): Fluticasone propionate is a synthetic corticosteroid that acts as an anti-inflammatory agent. It is highly effective in reducing airway inflammation, which is a hallmark of respiratory conditions like asthma. By inhibiting the release of inflammatory mediators and suppressing the body's immune response in the airways, fluticasone helps alleviate symptoms such as wheezing, coughing, and shortness of breath.
Salmeterol Xinafoate (6mcg): Salmeterol xinafoate is a long-acting beta-2 agonist (LABA). It acts by relaxing the smooth muscles in the airways, which helps to widen them and improve airflow. This bronchodilator effect helps relieve symptoms such as bronchoconstriction and shortness of breath.
Maxiflo Inhaler 250/6mcg works by combining the anti-inflammatory properties of fluticasone propionate and the bronchodilatory effects of salmeterol xinafoate. This dual-action mechanism allows the inhaler to address both the inflammation and constriction of the airways, which are common in respiratory conditions.
Fluticasone propionate, the corticosteroid component, reduces inflammation in the airways by inhibiting the production and release of inflammatory substances. This leads to a reduction in airway swelling and mucus production, which, in turn, alleviates symptoms and improves lung function.
Salmeterol xinafoate, the LABA component, acts by stimulating beta-2 receptors in the airway smooth muscles. This stimulation causes relaxation of the muscles, widening the airways and improving airflow. The bronchodilatory effect of salmeterol helps relieve symptoms such as bronchoconstriction and shortness of breath, allowing the individual to breathe more comfortably.
Maxiflo Inhaler 250/6mcg is primarily indicated for the management of various respiratory conditions, including:
Asthma: It is used for the long-term control and prevention of asthma symptoms in individuals who require both an inhaled corticosteroid and a long-acting beta-2 agonist.
Chronic Obstructive Pulmonary Disease (COPD): Maxiflo Inhaler may also be prescribed for the long-term treatment of COPD in patients with a history of exacerbations.
Proper usage of the Maxiflo Inhaler is crucial for its effectiveness. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Typically, the recommended dosage is as follows:
For adults and adolescents over the age of 12, the usual dose is one inhalation (250/6mcg) twice daily.
The inhaler should be used at the same times each day, and the two daily doses should be separated by approximately 12 hours.
The inhaler should be shaken well before each use, and the user should exhale completely before inhaling the medication. It's important to rinse the mouth with water after each use to reduce the risk of developing oral thrush.
If a patient is not receiving adequate relief from their symptoms or if they are using the inhaler more frequently than prescribed, they should consult their healthcare provider. This may indicate a need for a different treatment plan.
While Maxiflo Inhaler 250/6mcg is generally considered safe and effective when used as prescribed, it may cause some side effects. Common side effects may include:
Oral Thrush: This is a fungal infection in the mouth that can result from the use of inhaled corticosteroids. Rinsing the mouth after each use can help reduce the risk.
Hoarseness or Sore Throat: Some individuals may experience irritation in the throat.
Headache: Headaches are a relatively common side effect.
Nausea: A small number of users may experience nausea.
Palpitations: Salmeterol, the LABA component, may cause palpitations in some individuals.
Tremors: Tremors or shaking of the hands may occur in rare cases.
It's important to note that not everyone will experience these side effects, and some individuals may experience side effects not listed here. If side effects are severe, persistent, or bothersome, individuals should contact their healthcare provider.
Additionally, it's crucial to be aware of potential rare but serious side effects that may require immediate medical attention, such as worsening of respiratory symptoms, allergic reactions, and cardiovascular effects.
Before starting Maxiflo Inhaler 250/6mcg, it is essential to discuss the following precautions with a healthcare provider:
Allergies: Individuals should inform their healthcare provider of any known allergies to the active ingredients or other components of the inhaler.
Medical History: A thorough medical history, including any history of heart problems, high blood pressure, seizures, diabetes, and liver disease, should be disclosed to the healthcare provider.
Drug Interactions: Individuals should discuss any other medications they are taking, including prescription and over-the-counter drugs, herbal supplements, and vitamins. Certain medications may interact with Maxiflo Inhaler.
Pregnancy and Breastfeeding: The use of Maxiflo Inhaler during pregnancy and breastfeeding should be discussed with a healthcare provider, as the potential risks and benefits need to be considered.
Children: The safety and efficacy of Maxiflo Inhaler 250/6mcg in children under 12 years of age have not been established.
Worsening of Symptoms: If the inhaler does not provide adequate relief, or if symptoms worsen, individuals should promptly seek medical attention.
Regular Monitoring: Healthcare providers may recommend regular check-ups and lung function tests to monitor the individual's response to treatment and adjust the treatment plan as needed.
Maxiflo Inhaler should be stored at room temperature, away from direct sunlight and moisture. It should be kept out of reach of children.
Maxiflo Inhaler 250/6mcg is a combination inhaler that effectively addresses the symptoms and underlying causes of respiratory conditions such as asthma and COPD. By combining the anti-inflammatory properties of fluticasone propionate and the bronchodilatory effects of salmeterol xinafoate, this medication helps individuals breathe more comfortably and manage their condition. Proper usage, adherence to precautions, and regular communication with a healthcare provider are essential for achieving the